SCHEMBL6175264

SCHEMBL6175264

Nc1ccc2c(c1)cc(OC(=O)Nc1ccccc1)n2CCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 1/20 0.46
TP53 P04637 1/20 0.43
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
RECQL P46063 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPT P10636 6/20 0.39
USP2 O75604 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
RGS12 O14924 1/20 0.39
MGLL Q99685 1/20 0.37
GAA P10253 1/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.36
CCR2 P41597 1/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
EPHX1 P07099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174080 0.83 MAPT (0.45) ECE1RAB9ANPC1RECQLSMN1; SMN2
SCHEMBL6018900 0.81 ECE1 (0.66) ECE1TP53HTTCCR2
SCHEMBL6174014 0.71 PPARG (0.40) ECE1RAB9AMAPTKDM4EGAA
SCHEMBL6177715 0.71 ECE1 (0.43) ECE1RAB9ANPC1USP2MEN1
SCHEMBL8337177 0.68 KDM1A (0.60) ECE1MEN1KMT2AKDM4EHTT
SCHEMBL6018965 0.68 KDM1A (0.50) ECE1MEN1KMT2AHTTCCR2
SCHEMBL6018659 0.65 ECE1 (0.63) ECE1TP53RAB9ANPC1SMN1; SMN2
SCHEMBL15712747 0.65 CCR2 (0.74) CCR2
SCHEMBL6630165 0.64 RAB9A (0.68) TP53RAB9ANPC1RECQLSMN1; SMN2
SCHEMBL9200925 0.64 GAA (0.73) TP53RAB9ASMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432415-B1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2005-12-28 EP disclosed
EP-1432415-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2004-06-30 EP disclosed
WO-2003028719-A1 SUBSTITUTED 2,5-DIAMIDOINDOLES AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2003-04-10 WO disclosed